Study of the Safety and Efficacy of Apadenoson for Detection of Myocardial Perfusion Defects Using SPECT MPI
Status:
Terminated
Trial end date:
2012-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to see whether apadenoson is as effective as adenosine when used
as a pharmacological stress agent in myocardial SPECT-Imaging to detect defects in the supply
of blood to the heart muscle (myocardial perfusion defects). The study will also look at
whether apadenoson is better tolerated than adenosine when used in SPECT-MPI.